Fatal outcome reported in Chinese gene-editing clinical trial for brain therapy

A clinical trial in China aimed at treating a rare genetic disorder via brain-targeted gene therapy resulted in the death of a pediatric patient. The investigation highlights significant ethical and procedural concerns regarding the trial's oversight and transparency.